Jeffrey V. Poulton

EVP, Chief Financial Officer, Alnylam Pharmaceuticals, Inc.

Bought, 12 months

$0.0M

Sold, 12 months

$3.2M

Companies

Latest trade

Mar 4, 2026

Companies

Alnylam Pharmaceuticals, Inc.EVP, Chief Financial Officer −$5.0M

Trades

ALNY Sold 2,468 shares at $323.08 $0.8M Mar 4

ALNY Sold 2,206 shares at $327.65 $0.7M Mar 2

ALNY Sold 2,242 shares at $310.08 $0.7M Feb 13

ALNY Sold 2,780 shares at $362.87 $1.0M Jan 12

ALNY Sold 3,821 shares at $452.05 $1.7M Oct 2

Open-market trades from SEC Form 4 only: no grants, option exercises or gifts. People are matched by the name on their filings, so two people with the same name share this page. For information only — not investment advice.